Statins are currently the most widely prescribed lipid-lowering drugs. Indi
vidual statins are known to be metabolised by the CYP3A4 isoform of the cyt
ochrome P450 system. The effect of CYP3A4 inducers such as phenytoin on the
metabolism and efficacy of these agents is unknown. We report a patient wi
th familial hypercholesterolaemia and epilepsy in whom the introduction and
subsequent discontinuation of phenytoin were associated with marked change
s in the lipid response to treatment with simvastatin and atorvastatin. The
serum activity of gamma-glutamyl transpeptidase may have acted as a marker
of microsomal induction by phenytoin, since it rose markedly when phenytoi
n was introduced and returned to normal after it was discontinued.